Loading...

Anne Kathryn Schuckman, MD

TitleAssistant Professor of Clinical Urology
InstitutionUniversity of Southern California
DepartmentUrology
AddressNOR 7416
Health Sciences Campus
Los Angeles CA 90089-9178
Phone+1 323 865 3700
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    American Urological Association2006Murphy Scholar

    Collapse Overview 
    Collapse Overview
    Dr. Anne Schuckman graduated from Stanford University, and completed her medical training at the University of Southern California School of Medicine. She completed her residency training at LAC+USC Medical Center and her fellowship in urologic oncology under Dr. Donald Skinner at USC Norris Comprehensive Cancer Center.

    Dr. Schuckman’s areas if interest include testicular cancer, bladder cancer and urinary reconstruction. She performs both open and laparoscopic procedures, including laparoscopic nephrectomy and partial nephrectomy.


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Bazargani ST, Ghodoussipour S, Tse B, Miranda G, Cai J, Schuckman A, Daneshmand S, Djaladat H. The association between intraoperative fluid intake and postoperative complications in patients undergoing radical cystectomy with an enhanced recovery protocol. World J Urol. 2018 Mar; 36(3):401-407. PMID: 29299662.
      View in: PubMed
    2. Goldenberg MG, Nabhani J, Wallis CJD, Chopra S, Hung AJ, Schuckman A, Djaladat H, Daneshmand S, Desai MM, Aron M, Gill IS, Satkunasivam R. Feasibility of expert and crowd-sourced review of intraoperative video for quality improvement of intracorporeal urinary diversion during robotic radical cystectomy. Can Urol Assoc J. 2017 Oct; 11(10):331-336. PMID: 29382445.
      View in: PubMed
    3. Loh JM, Tran AL, Ji L, Groshen S, Daneshmand S, Schuckman A, Quinn DI, Dorff TB. Baseline Glomerular Filtration Rate and Cisplatin- Induced Renal Toxicity in Urothelial Cancer Patients. Clin Genitourin Cancer. 2017 Sep 06. PMID: 28958673.
      View in: PubMed
    4. Dorff TB, Ballas LK, Schuckman A. Current Management Strategy for Penile Cancer and Future Directions. Curr Oncol Rep. 2017 Aug; 19(8):54. PMID: 28664471.
      View in: PubMed
    5. Bazargani ST, Djaladat H, Ahmadi H, Miranda G, Cai J, Schuckman A, Daneshmand S. Gastrointestinal Complications Following Radical Cystectomy Using Enhanced Recovery Protocol. Eur Urol Focus. 2017 Apr 25. PMID: 28753885.
      View in: PubMed
    6. Djaladat H, Katebian B, Bazargani ST, Miranda G, Cai J, Schuckman A, Daneshmand S. 90-Day complication rate in patients undergoing radical cystectomy with enhanced recovery protocol: a prospective cohort study. World J Urol. 2017 Jun; 35(6):907-911. PMID: 27734131.
      View in: PubMed
    7. Clifford TG, Shah SH, Bazargani ST, Miranda G, Cai J, Wayne K, Djaladat H, Schuckman A, Daneshmand S. Prospective Evaluation of Continence Following Radical Cystectomy and Orthotopic Urinary Diversion Using a Validated Questionnaire. J Urol. 2016 Dec; 196(6):1685-1691. PMID: 27256205.
      View in: PubMed
    8. Dorff TB, Schuckman A, Schwartz R, Rashad S, Bulbul A, Cai J, Pinski J, Ma Y, Danenberg K, Skinner E, Quinn DI. Epidermal Growth Factor Receptor, Excision-Repair Cross-Complementation Group 1 Protein, and Thymidylate Synthase Expression in Penile Cancer. Clin Genitourin Cancer. 2016 10; 14(5):450-456.e1. PMID: 26935231.
      View in: PubMed
    9. Xu W, Daneshmand S, Bazargani ST, Cai J, Miranda G, Schuckman A, Djaladat H. Postoperative Pain Management after Radical Cystectomy: Comparing Traditional versus Enhanced Recovery Protocol Pathway. J Urol. 2015 Nov; 194(5):1209-13. PMID: 26021824.
      View in: PubMed
    10. Nabhani J, Ahmadi H, Schuckman A, Cai J, Miranda G, Djaladat H, Daneshmand S. Cost Analysis of the Enhanced Recovery After Surgery Protocol in Patients Undergoing Radical Cystectomy for Bladder Cancer. Eur Urol Focus. 2016 Apr; 2(1):92-96. PMID: 28723457.
      View in: PubMed
    11. Shah SH, Movassaghi K, Skinner D, Dalag L, Miranda G, Cai J, Schuckman A, Daneshmand S, Djaladat H. Ureteroenteric Strictures After Open Radical Cystectomy and Urinary Diversion: The University of Southern California Experience. Urology. 2015 Jul; 86(1):87-91. PMID: 25987494.
      View in: PubMed
    12. Hu B, Satkunasivam R, Schuckman A, Miranda G, Cai J, Daneshmand S. Urothelial carcinoma in bladder diverticula: outcomes after radical cystectomy. World J Urol. 2015 Oct; 33(10):1397-402. PMID: 25549760.
      View in: PubMed
    13. Mitra AP, Alemozaffar M, Harris BN, Schuckman A, Skinner EC, Daneshmand S. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy. Urology. 2014 Dec; 84(6):1420-6. PMID: 25306479.
      View in: PubMed
    14. Daneshmand S, Schuckman A, Bochner BH, Cookson MS, Downs TM, Gomella LG, Grossman HB, Kamat AM, Konety BR, Lee CT, Pohar KS, Pruthi RS, Resnick MJ, Smith ND, Witjes JA, Schoenberg MP, Steinberg GD. Hexaminolevulinate blue-light cystoscopy in non-muscle-invasive bladder cancer: review of the clinical evidence and consensus statement on appropriate use in the USA. Nat Rev Urol. 2014 Oct; 11(10):589-96. PMID: 25245244.
      View in: PubMed
    15. Hu B, Satkunasivam R, Schuckman A, Sherrod A, Cai J, Miranda G, Daneshmand S. Significance of perivesical lymph nodes in radical cystectomy for bladder cancer. Urol Oncol. 2014 Nov; 32(8):1158-65. PMID: 25238701.
      View in: PubMed
    16. Li X, Choi WW, Yan R, Yu H, Krasnoperov V, Kumar SR, Schuckman A, Klumpp DJ, Pan CX, Quinn D, Gill IS, Gill PS, Liu R. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder. PLoS One. 2014; 9(8):e105326. PMID: 25148033; PMCID: PMC4141800.
    17. Sun AJ, Djaladat H, Schuckman A, Miranda G, Cai J, Daneshmand S. Venous thromboembolism following radical cystectomy: significant predictors, comparison of different anticoagulants and timing of events. J Urol. 2015 Feb; 193(2):565-9. PMID: 25150642.
      View in: PubMed
    18. Patil MB, Montez J, Loh-Doyle J, Cai J, Skinner EC, Schuckman A, Thangathurai D, Skinner DG, Daneshmand S. Level III-IV inferior vena caval thrombectomy without cardiopulmonary bypass: long-term experience with intrapericardial control. J Urol. 2014 Sep; 192(3):682-8. PMID: 24704114.
      View in: PubMed
    19. Daneshmand S, Ahmadi H, Schuckman A, Mitra AP, Cai J, Miranda G, Djaladat H. Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol. 2014 Jul; 192(1):50-5. PMID: 24518775.
      View in: PubMed
    20. Mitra AP, Skinner EC, Schuckman A, Quinn DI, Dorff TB, Daneshmand S. Effect of gender on outcomes following radical cystectomy for urothelial carcinoma of the bladder: a critical analysis of 1,994 patients. Urol Oncol. 2014 Jan; 32(1):52.e1-9. PMID: 24239476.
      View in: PubMed
    21. Brown A, Ma Y, Danenberg K, Schuckman A, Pinski JK, Pagliaro LC, Quinn DI, Dorff TB. Epidermal growth factor receptor-targeted therapy in squamous cell carcinoma of the penis: a report of 3 cases. Urology. 2014 Jan; 83(1):159-65. PMID: 24238569.
      View in: PubMed
    22. Fairey AS, Daneshmand S, Skinner EC, Schuckman A, Cai J, Lieskovsky G. Long-term cancer control after radical prostatectomy and bilateral pelvic lymph node dissection for pT3bN0M0 prostate cancer in the prostate-specific antigen era. Urol Oncol. 2014 Feb; 32(2):85-91. PMID: 24183191.
      View in: PubMed
    23. Jayaratna IS, Mitra AP, Schwartz RL, Dorff TB, Schuckman A. Clinicopathologic characteristics and outcomes of penile cancer treated at tertiary care centers in the Western United States. Clin Genitourin Cancer. 2014 Apr; 12(2):138-42. PMID: 24210829.
      View in: PubMed
    24. Fairey AS, Daneshmand S, Wang L, Schuckman A, Lieskovsky G, Djaladat H, Cai J, Miranda G, Skinner EC. Impact of micropapillary urothelial carcinoma variant histology on survival after radical cystectomy. Urol Oncol. 2014 Feb; 32(2):110-6. PMID: 23499168.
      View in: PubMed
    25. Fairey AS, Daneshmand S, Quinn D, Dorff T, Dorin R, Lieskovsky G, Schuckman A, Cai J, Miranda G, Skinner EC. Neoadjuvant chemotherapy with gemcitabine/cisplatin vs. methotrexate/vinblastine/doxorubicin/cisplatin for muscle-invasive urothelial carcinoma of the bladder: a retrospective analysis from the University of Southern California. Urol Oncol. 2013 Nov; 31(8):1737-43. PMID: 23141776.
      View in: PubMed
    26. Mitra AP, Quinn DI, Dorff TB, Skinner EC, Schuckman A, Miranda G, Gill IS, Daneshmand S. Factors influencing post-recurrence survival in bladder cancer following radical cystectomy. BJU Int. 2012 Mar; 109(6):846-54. PMID: 21812902.
      View in: PubMed
    27. Shuch B, Crispen PL, Leibovich BC, LaRochelle JC, Pouliot F, Pantuck AJ, Liu W, Crepel M, Schuckman A, Rigaud J, Bouchot O, Patard JJ, Skinner D, Belldegrun AS, Blute ML. Cardiopulmonary bypass and renal cell carcinoma with level IV tumour thrombus: can deep hypothermic circulatory arrest limit perioperative mortality? BJU Int. 2011 Mar; 107(5):724-728. PMID: 20626391.
      View in: PubMed
    28. Schuckman A, Stein JP, Skinner D. Surgical considerations for elderly urologic oncology patients. Urol Oncol. 2009 Nov-Dec; 27(6):628-32. PMID: 19879473.
      View in: PubMed